Delivery Order SPE2DE24D0013-SPE2D626F9925
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $2,269.40 firm fixed-price delivery order to Cepheid Inc. on October 31, 2025, with completion targeted for November 7, 2025. This delivery order, designated GXCARBAR-10, represents a continuation of Cepheid's longstanding role as a primary federal supplier of molecular diagnostic solutions, particularly for infectious disease testing and detection capabilities. The contract utilizes no set-aside designation and will be performed at...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a delivery order valued at $52,387.20 to Cepheid Inc. on September 26, 2025, with an ultimate completion date of October 3, 2025. This firm fixed-price delivery order (contract number 4569624736, XPRS4PLEX-10) carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. The award represents a discrete purchase under one of Cepheid's larger indefinite delivery...
- The Defense Logistics Agency (DLA), under the Medical Supply Chain program, awarded a delivery order valued at $1,648.38 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on August 12, 2025. This firm fixed-price delivery order, without set-aside designation, represents a continuation of Cepheid's ongoing provision of diagnostic testing solutions to federal defense and healthcare agencies. The contract is scheduled for ultimate completion by August 19, 2025,...
- The Defense Logistics Agency Medical Supply Chain awarded a $13,600 firm fixed-price delivery order to Cepheid Inc. on November 4, 2025, with an ultimate completion date of November 12, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing supplies and reagents for detecting COVID-19, influenza, and respiratory syncytial virus. Cepheid, headquartered in Sunnyvale, California, is a leading federal supplier of advanced molecular diagnostic systems and...
- Cepheid, a molecular diagnostic solutions manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $18,433.60 by the Defense Logistics Agency's Medical Supply Chain division on September 22, 2025. The delivery order, which carries no set-aside designation, is scheduled for ultimate completion by September 29, 2025. This award represents a continuation of Cepheid's established relationship with federal healthcare agencies in supplying diagnostic...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $27,650.40 firm fixed-price delivery order to Cepheid Inc. on September 18, 2025, with completion targeted for September 25, 2025. The delivery order, identified as XPRSMVP-10 (Contract Number 4569505244), is being performed at Cepheid's headquarters in Sunnyvale, California. This award carries no set-aside designation and represents a discrete procurement under the company's broader federal contracting relationship with...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $5,440 firm fixed-price delivery order (4569923610) by the Defense Logistics Agency Medical Supply Chain on November 5, 2025, with an ultimate completion date of November 13, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus—consistent with Cepheid's core competency in rapid molecular diagnostic testing...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,395.95 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price delivery order, designated 4569773284 under the contract vehicle GXCT/NG-10, represents work to be performed at Cepheid's Sunnyvale facility. The award carries no set-aside designation, reflecting Cepheid's competitive positioning as an...
- The U.S. Defense Logistics Agency (Medical Supply Chain) awarded a $12,086.88 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The delivery order, issued on August 6, 2025, with completion targeted for August 13, 2025, is designated XPCOV2/FLU/RSV-10 and carries no set-aside designation. This award represents a delivery order issued under one of Cepheid's existing Indefinite Delivery Vehicle (IDV) contracts, likely the...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents, was awarded a delivery order valued at $5,236.00 by the Defense Logistics Agency Medical Supply Chain on October 27, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for diagnostic testing supplies supporting detection of COVID-19, influenza, and respiratory syncytial virus, with a firm fixed-price structure and ultimate completion date of November 10, 2025. The contract...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F9925Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a $1,757.00 firm fixed-price delivery order to Cepheid Inc. on November 5, 2025, with an ultimate completion date of November 20, 2025. This delivery order, issued without a set-aside designation, supports the agency's molecular diagnostic supply requirements and leverages Cepheid's established expertise as a primary federal supplier of diagnostic solutions. The work will be performed at Cepheid's headquarters in Sunnyvale, California. This award represents a continuation of the company's extensive engagement with federal healthcare agencies, including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and the U.S. Coast Guard, where Cepheid provides advanced molecular diagnostic systems, reagents, and testing capabilities. Cepheid's federal contracting profile demonstrates substantial capability in supplying diagnostic equipment and consumables for infectious disease detection, including COVID-19, influenza, and other respiratory pathogens. The company currently maintains significant indefinite delivery contracts with the Veterans Affairs system, including a $32.8 million contract with VISN 6 extending through September 2030 and a $6.7 million contract with VISN 17 extending through December 2029, which generate ongoing delivery orders for diagnostic reagents and test kits. This delivery order from the Defense Logistics Agency's Medical Supply Chain reflects Cepheid's competitive positioning in federal molecular diagnostics procurement and its role in supporting critical diagnostic capabilities across the federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 11/5/25 |